Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia-Reference-Cited by-同舟云学术

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

Published:2001-09 Issue:5 Volume:88 Page:504-508
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Olsson Anders G,Pears John,McKellar John,Mizan Jacques,Raza Ali

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Pharmacological properties of ZD4522—A new HMG-CoA reductase inhibitor;Smith;Atherosclerosis,2000

2. Selectivity of ZD4522 for inhibition of cholesterol synthesis in hepatic versus non-hepatic cells;Buckett;Atherosclerosis,2000

3. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia;Jones;Am J Cardiol,1998

4. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor;Nawrocki;Arterioscler Thromb Vasc Biol,1995

5. Assessing dietary adherence in the Multiple Risk Factor Intervention Trial (MRFIT). I. Use of a dietary monitoring tool;Remmell;J Am Diet Assoc,1980

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Cardiovascular Disease Treated with High-Intensity Statins: The TERESA Study;Journal of Clinical Medicine;2023-04-28

2. Prevalence of statin intolerance: a meta-analysis;European Heart Journal;2022-02-16

3. Guidelines for the Prevention of Symptomatic Cardiovascular Disease, Based upon the Presence of Coronary Artery Calcified Plaque—Provided by the Society for the Prevention of Symptomatic Heart Disease;World Journal of Cardiovascular Diseases;2022

4. Prevention of Coronary Heart Disease: A Translational Clinical Challenge;World Journal of Cardiovascular Diseases;2022

5. Inhibition of Scavenger Receptor Class B Type 1 (SR-B1) Expression and Activity as a Potential Novel Target to Disrupt Cholesterol Availability in Castration-Resistant Prostate Cancer;Pharmaceutics;2021-09-18